financetom
Business
financetom
/
Business
/
Indian regulator approves $8.5 billion Disney-Reliance media merger
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Indian regulator approves $8.5 billion Disney-Reliance media merger
Aug 28, 2024 4:20 AM

BENGALURU (Reuters) - India's competition regulator has approved the $8.5 billion merger of Reliance Industries and Disney's ( DIS ) Indian media assets, subject to certain voluntary modifications, it said in a post on social media platform X on Wednesday.

The Competition Commission of India did not disclose the concessions made.

Disney ( DIS ) and Reliance had offered some concessions to secure an the approval for their merger, Reuters reported last week, citing sources.

Reliance-Disney ( DIS ) aims to create India's biggest entertainment player to compete with Sony, Netflix and Amazon with 120 TV channels and two streaming services.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brenmiller Energy Selected to Provide Storage System for Spanish Thermal Energy Project
Brenmiller Energy Selected to Provide Storage System for Spanish Thermal Energy Project
Dec 30, 2024
09:32 AM EST, 12/30/2024 (MT Newswires) -- Brenmiller Energy ( BNRG ) said Monday its bGen Zero thermal energy storage system was chosen for a project in Spain developed by Recursos de la Biomasa, supported by a European Union grant under the NextGenerationEU program. Financial terms were not provided. The company said the project, delivered through Brenmiller Europe - a...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
Dec 30, 2024
By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo. Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune system's ability to fight cancer by removing its natural brakes. Like other PD-1...
--Nvidia Closes Acquisition of Run:ai
--Nvidia Closes Acquisition of Run:ai
Dec 30, 2024
09:38 AM EST, 12/30/2024 (MT Newswires) -- Price: 135.43, Change: -1.58, Percent Change: -1.15 ...
United States Antimony Gets Second Antimony Supply Contract; Files $100 Million Shelf
United States Antimony Gets Second Antimony Supply Contract; Files $100 Million Shelf
Dec 30, 2024
09:42 AM EST, 12/30/2024 (MT Newswires) -- United States Antimony ( UAMY ) said Monday it has signed a second contract for an additional supply of antimony ore. The company said that the first new inbound global shipments will come from Thailand and will comprise 50 wet metric tons, or two full containers. The containers are expected to arrive at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved